Cross-national epidemiology of DSM-IV major depressive episode, BMC Medicine, vol.106, issue.1-2, p.90, 2011. ,
DOI : 10.1016/j.jad.2007.07.023
URL : https://hal.archives-ouvertes.fr/inserm-00617550
Global Burden of Disease, 2008. ,
DOI : 10.1016/B978-0-12-803678-5.00175-2
Manuel de psychiatrie. Issy-les-Moulineaux, 2012. ,
Psychopharmacologie essentielle : Bases neuroscientifiques et applications pratiques. 2e édition, 2010. ,
Residual symptoms after partial remission: an important outcome in depression, Psychological Medicine, vol.165, issue.06, p.11711180, 1995. ,
DOI : 10.1080/02699938808410927
Major depressive disorder: A prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse, Journal of Affective Disorders, vol.50, issue.2-3, pp.2-397108, 1998. ,
DOI : 10.1016/S0165-0327(98)00138-4
The STAR*D project results: A comprehensive review of findings, Current Psychiatry Reports, vol.5, issue.Suppl16, p.44959, 2007. ,
DOI : 10.1007/s11920-007-0061-3
Antidepressants and their onset of action: a major clinical, methodological and pronostical issue], Encephale. janv, vol.34, issue.1, p.7381, 2008. ,
Ketamine???Its Pharmacology and Therapeutic Uses, Anesthesiology, vol.56, issue.2, p.119136, 1982. ,
DOI : 10.1097/00000542-198202000-00007
Taming the Ketamine Tiger, Anesthesiology, vol.113, issue.3, p.678684, 1965. ,
DOI : 10.1097/ALN.0b013e3181ed09a2
Adverse events associated with ketamine for procedural sedation in adults, The American Journal of Emergency Medicine, vol.26, issue.9 ,
DOI : 10.1016/j.ajem.2007.12.005
ketamine abuse: first medical evidence of harms we should confront, Addict Abingdon Engl. janv, vol.105, issue.1, p.134135, 2010. ,
Antidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL-82.0715), Pharmacology Biochemistry and Behavior, vol.52, issue.3, p.621627, 1995. ,
DOI : 10.1016/0091-3057(95)00155-P
Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid, J Pharmacol Exp Ther. juin, vol.265, issue.3, p.13801386, 1993. ,
Antidepressant effects of ketamine in depressed patients, Biological Psychiatry, vol.47, issue.4, p.351354, 2000. ,
DOI : 10.1016/S0006-3223(99)00230-9
A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression, Archives of General Psychiatry, vol.63, issue.8, p.856864, 2006. ,
DOI : 10.1001/archpsyc.63.8.856
Ketamine for depression: where do we go from here? Biol Psychiatry, p.537547, 2012. ,
Effects of Intravenous Ketamine on Explicit and Implicit Measures of Suicidality in Treatment-Resistant Depression, Biological Psychiatry, vol.66, issue.5, p.522526, 2009. ,
DOI : 10.1016/j.biopsych.2009.04.029
-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder, The Journal of Clinical Psychiatry, vol.71, issue.12, p.16051611, 2010. ,
DOI : 10.4088/JCP.09m05327blu
URL : https://hal.archives-ouvertes.fr/hal-00591663
Small-Dose Ketamine Improves the Postoperative State of Depressed Patients, Anesthesia & Analgesia, vol.95, issue.1, p.1148, 2002. ,
DOI : 10.1097/00000539-200207000-00020
Antidepressant Effect of Ketamine During ECT, American Journal of Psychiatry, vol.162, issue.7, p.13851386, 2005. ,
DOI : 10.1176/appi.ajp.162.7.1385
Rapid Relief of Severe Major Depressive Disorder by Use of Preoperative Ketamine and Electroconvulsive Therapy, The Journal of ECT, vol.23, issue.1, p.2325, 2007. ,
DOI : 10.1097/01.yct.0000263257.44539.23
Ketofol in electroconvulsive therapy anesthesia: two stones for one bird, Journal of Anesthesia, vol.17, issue.4, p.562567, 2012. ,
DOI : 10.1007/s00540-012-1378-6
Rapid Antidepressant Effect of Ketamine in the Electroconvulsive Therapy Setting, The Journal of ECT, vol.28, issue.3, p.157161, 2012. ,
DOI : 10.1097/YCT.0b013e31824f8296
Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression, Biological Psychiatry, vol.74, issue.4, 2012. ,
DOI : 10.1016/j.biopsych.2012.06.022
Course of Improvement in Depressive Symptoms to a Single Intravenous Infusion of Ketamine vs Add-on Riluzole: Results from a 4-Week, Double-Blind, Placebo-Controlled Study, Neuropsychopharmacology, vol.63, issue.6, p.15261533, 2012. ,
DOI : 10.1038/npp.2011.338
Ketamine followed by memantine for the treatment of major depression, Aust N Z J Psychiatry. févr, vol.42, issue.2, p.170, 2008. ,
The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methylaspartate, Br J Pharmacol. juin, vol.79, issue.2, p.565575, 1983. ,
The Role of the Tripartite Glutamatergic Synapse in the Pathophysiology and Therapeutics of Mood Disorders, The Neuroscientist, vol.36, issue.13, p.525539, 2009. ,
DOI : 10.1177/1073858409336093
Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders, Nature Reviews Drug Discovery, vol.265, issue.5, p.426437, 2008. ,
DOI : 10.1176/appi.ajp.163.1.153
The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention, Neurochemistry International, vol.51, issue.6-7, pp.6-7333355, 2007. ,
DOI : 10.1016/j.neuint.2007.03.012
Glutamate-Based Antidepressants: Preclinical Psychopharmacology, Biological Psychiatry, vol.73, issue.12, p.11251132, 2013. ,
DOI : 10.1016/j.biopsych.2013.01.021
Rapid-Acting Glutamatergic Antidepressants: The Path to Ketamine and Beyond, Biological Psychiatry, vol.73, issue.12, p.11331141, 2013. ,
DOI : 10.1016/j.biopsych.2013.03.026
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists, Science, vol.329, issue.5994, p.959964, 2010. ,
DOI : 10.1126/science.1190287
Brain-Derived Neurotrophic Factor Val66Met Allele Impairs Basal and Ketamine-Stimulated Synaptogenesis in Prefrontal Cortex, Biological Psychiatry, vol.71, issue.11, p.9961005, 2012. ,
DOI : 10.1016/j.biopsych.2011.09.030
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3290730
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses, Nature, vol.96, issue.7354, p.9195, 2011. ,
DOI : 10.1038/nature10130
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3172695
The Role of Eukaryotic Elongation Factor 2 Kinase in Rapid Antidepressant Action of Ketamine, Biological Psychiatry, vol.73, issue.12, p.11991203, 2013. ,
DOI : 10.1016/j.biopsych.2012.09.006
Selective Loss of Brain-Derived Neurotrophic Factor in the Dentate Gyrus Attenuates Antidepressant Efficacy, Biological Psychiatry, vol.63, issue.7 ,
DOI : 10.1016/j.biopsych.2007.09.019
URL : https://hal.archives-ouvertes.fr/hal-00343691
Essential role of brainderived neurotrophic factor in adult hippocampal function, Proc Natl Acad Sci U S A. 20 juill, vol.101, issue.29, p.1082710832, 2004. ,
URL : https://hal.archives-ouvertes.fr/hal-00142913
Synaptic Dysfunction in Depression: Potential Therapeutic Targets, Science, vol.338, issue.6103, p.6872, 2012. ,
DOI : 10.1126/science.1222939
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424898
Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of ??-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors, Biological Psychiatry, vol.63, issue.4, p.349352, 2008. ,
DOI : 10.1016/j.biopsych.2007.05.028
The Oxford handbook of transcranial stimulation. Oxford, 2008. ,
DOI : 10.1093/oxfordhb/9780198568926.001.0001
Evidence for Increased Glutamatergic Cortical Facilitation in Children and Adolescents With Major Depressive Disorder, JAMA Psychiatry, vol.70, issue.3, p.291299, 2013. ,
DOI : 10.1001/2013.jamapsychiatry.24
Corticocortical inhibition in human motor cortex., The Journal of Physiology, vol.471, issue.1, p.501519, 1993. ,
DOI : 10.1113/jphysiol.1993.sp019912
GABA as an inhibitory neurotransmitter in human cerebral cortex, J Neurophysiol. nov, vol.62, issue.5, p.10181027, 1989. ,
Intracortical inhibition and facilitation in the conventional paired TMS paradigm, Electroencephalogr Clin Neurophysiol, vol.51, p.127136, 1999. ,
Complex modulation of human motor cortex excitability by the specific serotonin re-uptake inhibitor sertraline, Neuroscience Letters, vol.319, issue.2, p.116120, 2002. ,
DOI : 10.1016/S0304-3940(01)02563-0
Pharmacology of TMS, Suppl Clin Neurophysiol, vol.56, p.226231, 2003. ,
DOI : 10.1093/oxfordhb/9780198568926.013.0013
Mirtazapine increases cortical excitability in healthy controls and epilepsy patients with major depression, Journal of Neurology, Neurosurgery & Psychiatry, vol.76, issue.4, p.527533, 2005. ,
DOI : 10.1136/jnnp.2004.037010
Dextromethorphan decreases the excitability of the human motor cortex, Neurology, vol.51, issue.5, p.13201324, 1998. ,
DOI : 10.1212/WNL.51.5.1320
Ketamine Increases Human Motor Cortex Excitability to Transcranial Magnetic Stimulation, The Journal of Physiology, vol.109, issue.2, p.485496, 2003. ,
DOI : 10.1113/jphysiol.2002.030486
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2342642
Psychiatric safety of ketamine in psychopharmacology research, Psychopharmacology, vol.63, issue.Suppl 2, pp.253-260, 2007. ,
DOI : 10.1007/s00213-007-0706-2
Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study, Addiction, vol.38, issue.1, p.121133, 2010. ,
DOI : 10.1111/j.1360-0443.2009.02761.x
Ketamine-Associated Urinary Tract Dysfunction: An Underrecognized Clinical Entity, Urologia Internationalis, vol.89, issue.1, p.9396, 2012. ,
DOI : 10.1159/000338098
Benefits From Antidepressants, Archives of General Psychiatry, vol.69, issue.6, p.572579, 2012. ,
DOI : 10.1001/archgenpsychiatry.2011.2044
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3371295
Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors, The British Journal of Psychiatry, vol.178, issue.3, p.234241, 2001. ,
DOI : 10.1192/bjp.178.3.234
Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis, The British Journal of Psychiatry, vol.180, issue.5, p.396404, 2002. ,
DOI : 10.1192/bjp.180.5.396
CortExTool: a signal processing toolbox for cortical excitability by transcranial magnetic stimulation. 11th Meet Fr Neurosci Soc, 2013. ,
A meta-analysis of cortical inhibition and excitability using transcranial magnetic stimulation in psychiatric disorders, Clinical Neurophysiology, vol.124, issue.7, p.13091320, 2013. ,
DOI : 10.1016/j.clinph.2013.01.014
Relationship of ketamine's antidepressant and psychotomimetic effects in unipolar depression, Neuro Endocrinol Lett, vol.34, issue.4, p.287293, 2013. ,
Early Improvement in the First 2 Weeks as a Predictor of Treatment Outcome in Patients With Major Depressive Disorder, The Journal of Clinical Psychiatry, vol.70, issue.3, p.344353, 2009. ,
DOI : 10.4088/JCP.07m03780
Cortical Excitability and Response Variability of Transcranial Magnetic Stimulation, Journal of Clinical Neurophysiology, vol.13, issue.2, p.164171, 1996. ,
DOI : 10.1097/00004691-199603000-00007
The cortical silent period: intrinsic variability and relation to the waveform of the transcranial magnetic stimulation pulse, Clinical Neurophysiology, vol.115, issue.5, p.10761082, 2004. ,
DOI : 10.1016/j.clinph.2003.12.025
Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression, Biological Psychiatry, vol.67, issue.2, p.139145, 2010. ,
DOI : 10.1016/j.biopsych.2009.08.038
[Translation and validation of a French version of the Young Mania Rating Scale (YMRS)], ):499505. Young mania rating scale (YMRS), 2003. ,